Page last updated: 2024-09-05

sorafenib and Delayed Hypersensitivity

sorafenib has been researched along with Delayed Hypersensitivity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, YH; Qu, BQ; Song, R; Xu, Q; Zhao, W1

Other Studies

1 other study(ies) available for sorafenib and Delayed Hypersensitivity

ArticleYear
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation.
    Leukemia, 2008, Volume: 22, Issue:6

    Topics: Amino Acid Sequence; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blood Cells; Blotting, Western; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; G1 Phase; Humans; Hypersensitivity, Delayed; Immunization; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Niacinamide; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-raf; Pyridines; Receptors, Vascular Endothelial Growth Factor; Resting Phase, Cell Cycle; Sequence Homology, Amino Acid; Sorafenib; T-Lymphocytes

2008